Saidal Secures Commercial Breakthrough in Mauritania with Key Partnership

During the 7th Algerian Products Fair in Nouakchott, the state-owned pharmaceutical group Saidal signed a major partnership agreement with Mauritanian company Chinguity Pharma. This partnership includes the export of over 200 pharmaceutical products to Mauritania, marking a significant commercial milestone after a year of negotiations.

The collaboration between Saidal and Chinguity Pharma aims to address the growing pharmaceutical needs in Mauritania. Dr. Atmane Meddad, Saidal's export director, confirmed the registration of 220 pharmaceutical products with Mauritanian health authorities, which will soon be available for distribution across the country.

Beyond exports, the partnership includes an industrial component. Chinguity Pharma is in the process of completing a pharmaceutical plant, which will soon produce locally made medicines with technical assistance from Saidal. Initially, production will focus on therapeutic syrups and generic tablets, with plans to expand to diabetes treatments, cardiovascular drugs, and anti-cancer medications.

Saidal has set its sights on West Africa, using Mauritania as a gateway to a market of 300 million consumers. The Algerian Union Bank (AUB) presence in Mauritania plays a key role in facilitating the project. With Chinguity Pharma's established network across West and Central Africa, the partnership positions Saidal for rapid expansion into new markets.

The partnership is part of Saidal’s broader strategy to expand globally, with product registrations already underway in eight other countries, including Senegal, Ethiopia, Yemen, Libya, and Tunisia. The group is also investing in developing pharmaceutical raw materials to enhance its competitiveness in the Middle East and Europe.

Saidal’s partnership with Chinguity Pharma not only secures its entry into Mauritania but also serves as a strategic step in expanding into the wider West African market. This marks a significant leap in the Algerian pharmaceutical industry’s export ambitions.